calendar
24,846 catalysts · 5,282 approval · 5,000 device 510k · 4,728 grant · 3,045 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
24,846 catalysts · 5,282 approval · 5,000 device 510k · 4,728 grant · 3,045 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: SUBLINGUAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: UCB INC. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: SUBLINGUAL
Sponsor: LEO PHARMA AS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: SUBLINGUAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: SUBLINGUAL
Sponsor: BARR. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: UNICHEM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: INVAGEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET. Route: SUBLINGUAL
Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: WATSON LABS TEVA. Form: CAPSULE. Route: ORAL
Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: WES PHARMA INC. Form: TABLET. Route: SUBLINGUAL
Sponsor: IPSEN. Form: CAPSULE. Route: ORAL